evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/geneAliases/4,gene/geneAliases/5,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract
18920,GENE_BACKGROUND,,"SRSF2 encodes serine/arginine-rich splicing factor 2, an RNA splicing factor. Mutations result in aberrant pre-mRNA splicing and exon mis-recognition (PMID:26124281, 25965569). In hematopoietic cells, key regulatory genes such as EZH2 are mis-spliced with its mutation (PMID:25965569). Mutations cluster at specific sites and can affect RNA recognition (PMID:26261309). SRSF2 mutations are found in myelodysplastic syndrome, secondary acute myeloid leukemia, and myeloid disorders (PMID:21909114, 25550361, 25231745, 26464169, 23660863). Targeted inhibition of the spliceosome may be a therapeutic strategy in spliceosome mutant disease (PMID:26575690).",,2017-01-18,,6427,SRSF2,serine and arginine rich splicing factor 2,False,ENST00000359995,NM_003016.4,SFRS2A,PR264,SC35,SFRS2,SRp30b,SC-35,False,26124281,"SRSF2 Is Essential for Hematopoiesis, and Its Myelodysplastic Syndrome-Related Mutations Dysregulate Alternative Pre-mRNA Splicing.",Molecular and cellular biology,2018-09-01T20:15:00,35,17,3071-82,Komeno Y et al,doi: 10.1128/MCB.00202-15,,0001-09-01,,25550361,Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.,Blood,2018-02-26T20:15:00,125,9,1367-76,Lindsley RC et al,doi: 10.1182/blood-2014-11-610543,,0001-02-26,,25965569,SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition.,Cancer cell,2018-05-11T20:15:00,27,5,617-30,Kim E et al,doi: 10.1016/j.ccell.2015.04.006,,0001-05-11,,26464169,"Additional mutations in SRSF2, ASXL1 and/or RUNX1 identify a high-risk group of patients with KIT D816V(+) advanced systemic mastocytosis.",Leukemia,2018-01-01T20:16:00,30,True,136-43,Jawhar M et al,doi: 10.1038/leu.2015.284,,0001-01-01,,26261309,Disease-associated mutation in SRSF2 misregulates splicing by altering RNA-binding affinities.,Proceedings of the National Academy of Sciences of the United States of America,2018-08-25T20:15:00,112,34,E4726-34,Zhang J et al,doi: 10.1073/pnas.1514105112,,0001-08-25,,23660863,SRSF2 mutation is present in the hypercellular and prefibrotic stage of primary myelofibrosis.,Blood,2018-05-09T20:13:00,121,19,4011-2,Lehmann U et al,doi: 10.1182/blood-2012-11-467662,,0001-05-09,,21909114,Frequent pathway mutations of splicing machinery in myelodysplasia.,Nature,2018-09-11T20:11:00,478,7367,1964-09-01,Yoshida K et al,doi: 10.1038/nature10496,,0001-09-11,,25231745,0001-05-01,Leukemia,2018-01-01T20:15:00,29,True,253-5,Bartels S et al,doi: 10.1038/leu.2014.277,,0001-01-01,,26575690,"RNA splicing, cell signaling, and response to therapies.",Current opinion in oncology,2018-01-01T20:16:00,28,True,58-64,Abou Faycal C et al,doi: 10.1097/CCO.0000000000000254,,0001-01-01,
18919,GENE_SUMMARY,,SRSF2 encodes a RNA splicing factor. Mutations are found in hematologic disorders.,,2017-01-18,,6427,SRSF2,serine and arginine rich splicing factor 2,False,ENST00000359995,NM_003016.4,SFRS2A,PR264,SC35,SFRS2,SRp30b,SC-35,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
